Reliability of a self-reported questionnaire assessing the use of cannabis products to treat chronic pain

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-04 · read from full text

This preprint studied the development and test-retest reliability of a 24-item self-reported questionnaire intended to measure cannabis product use for chronic pain, including pain conditions, product types, methods of use, main cannabinoid concentrations, and concurrent use of other pain therapies. The questionnaire’s content validity was refined by an expert committee, and its reliability was assessed using a two-round longitudinal survey of 158 participants with chronic pain conducted between November 2023 and January 2024, with agreement quantified by kappa and weighted kappa; items were considered high reliability when kappa ≥ 0.61 per Landis and Koch. Most items related to cannabis use showed high reliability, while some items had only moderate reliability (0.41 ≤ kappa < 0.61), notably those capturing the type of pain and type of cannabinoids. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match related to chronic pelvic pain conditions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Background : Cannabis-based products are increasingly used worldwide for chronic pain. However, there is a lack of reliable instruments assessing cannabis exposure. Objective : To develop a questionnaire measuring the use of cannabis to manage chronic pain and assess its reliability. Method : A 24-item questionnaire assessing pain conditions, the type of cannabis products that were used, the methods of use, the concentration of main cannabinoids, and the use of other pain therapies was developed. An expert committee was convened to enhance the content validity of the questionnaire, to improve it, and a longitudinal survey was conducted to test the test-retest reliability of the final version. A two-round survey of 158 participants with chronic pain was conducted between November 2023 and January 2024. Kappa and weighted kappa coefficients were calculated to assess the agreement between the responses of the two rounds. According to the criteria of Landis and Koch, items with a kappa ≥ 0.61 were considered as having a high reliability. Results : The average age of participants was 38 years and the proportion of females was 53.5%. Most of the items assessing the use of cannabis products yielded a high reliability (kappa ≥ 0.61). Items with moderate reliability (0.41 ≤ Kappa < 0.61) included the type of pain and the type of cannabinoids used. Conclusion : The results suggest that the questionnaire developed in this study is a reliable tool for assessing cannabis use in patients with chronic pain in clinical or research settings.
Full text 13,188 characters · extracted from preprint-html · click to expand
Reliability of a self-reported questionnaire assessing the use of cannabis products to treat chronic pain | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Reliability of a self-reported questionnaire assessing the use of cannabis products to treat chronic pain Edeltraut Kröger, Clermont E. Dionne, Zoumana Cheick Bérété, Malek Amiri, and 2 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8050715/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background : Cannabis-based products are increasingly used worldwide for chronic pain. However, there is a lack of reliable instruments assessing cannabis exposure. Objective : To develop a questionnaire measuring the use of cannabis to manage chronic pain and assess its reliability. Method : A 24-item questionnaire assessing pain conditions, the type of cannabis products that were used, the methods of use, the concentration of main cannabinoids, and the use of other pain therapies was developed. An expert committee was convened to enhance the content validity of the questionnaire, to improve it, and a longitudinal survey was conducted to test the test-retest reliability of the final version. A two-round survey of 158 participants with chronic pain was conducted between November 2023 and January 2024. Kappa and weighted kappa coefficients were calculated to assess the agreement between the responses of the two rounds. According to the criteria of Landis and Koch, items with a kappa ≥ 0.61 were considered as having a high reliability. Results : The average age of participants was 38 years and the proportion of females was 53.5%. Most of the items assessing the use of cannabis products yielded a high reliability (kappa ≥ 0.61). Items with moderate reliability (0.41 ≤ Kappa < 0.61) included the type of pain and the type of cannabinoids used. Conclusion : The results suggest that the questionnaire developed in this study is a reliable tool for assessing cannabis use in patients with chronic pain in clinical or research settings. Epidemiology chronic pain medical cannabis questionnaire test-retest reliability Full Text Additional Declarations The authors declare no competing interests. Supplementary Files 2.CanQuestEN.pdf English version of the medical cannabis use questionnaire Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8050715","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":541177045,"identity":"5a8096c8-823e-4610-bf67-c9ba729a390d","order_by":0,"name":"Edeltraut Kröger","email":"","orcid":"","institution":"Faculty of pharmacy, Université Laval","correspondingAuthor":false,"prefix":"","firstName":"Edeltraut","middleName":"","lastName":"Kröger","suffix":""},{"id":541177046,"identity":"ddec04b5-71f1-4e59-936d-9237b9d38fad","order_by":1,"name":"Clermont E. Dionne","email":"","orcid":"","institution":"Faculty of medicine, Université Laval","correspondingAuthor":false,"prefix":"","firstName":"Clermont","middleName":"E.","lastName":"Dionne","suffix":""},{"id":541177047,"identity":"72e1b347-bc3c-47a4-8567-8251a9d6680c","order_by":2,"name":"Zoumana Cheick Bérété","email":"","orcid":"https://orcid.org/0000-0002-1263-5623","institution":"Faculty of pharmacy, Université Laval","correspondingAuthor":false,"prefix":"","firstName":"Zoumana","middleName":"Cheick","lastName":"Bérété","suffix":""},{"id":541177048,"identity":"ff717ef6-5cc2-4d97-ae7f-5f9abb266c17","order_by":3,"name":"Malek Amiri","email":"","orcid":"","institution":"Université Laval","correspondingAuthor":false,"prefix":"","firstName":"Malek","middleName":"","lastName":"Amiri","suffix":""},{"id":541177049,"identity":"6dad5dbf-6165-48a7-b63a-b054c892b236","order_by":4,"name":"Anaïs Lacasse","email":"","orcid":"","institution":"University of Quebec in Abitibi-Témiscamingue","correspondingAuthor":false,"prefix":"","firstName":"Anaïs","middleName":"","lastName":"Lacasse","suffix":""},{"id":541177050,"identity":"6f67964b-96f6-44cc-8ced-b8e8f2cd6477","order_by":5,"name":"Arsène Zongo","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0001-8812-3088","institution":"Faculty of pharmacy, Université Laval","correspondingAuthor":true,"prefix":"","firstName":"Arsène","middleName":"","lastName":"Zongo","suffix":""}],"badges":[],"createdAt":"2025-11-06 18:30:55","currentVersionCode":1,"declarations":{"humanSubjects":true,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":true,"humanSubjectConsent":true,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-8050715/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8050715/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":95529325,"identity":"0c0aa652-b13c-4080-8168-1e119d14f55b","added_by":"auto","created_at":"2025-11-10 10:16:59","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":489302,"visible":true,"origin":"","legend":"","description":"","filename":"1.ManuscriptCanQuest.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8050715/v1_covered_ef47601e-0cbf-498f-bfa9-47c8b1100067.pdf"},{"id":95497956,"identity":"7c98da88-894c-4f6d-a113-0d816108c5b1","added_by":"auto","created_at":"2025-11-10 04:53:56","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":262629,"visible":true,"origin":"","legend":"\u003cp\u003eEnglish version of the medical cannabis use questionnaire\u0026nbsp;\u003c/p\u003e","description":"","filename":"2.CanQuestEN.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8050715/v1/abc3ecb884447d203af54d60.pdf"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"\u003cp\u003eReliability of a self-reported questionnaire assessing the use of cannabis products to treat chronic pain\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"Réseau québécois de recherche sur les médicaments","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"chronic pain, medical cannabis, questionnaire, test-retest reliability","lastPublishedDoi":"10.21203/rs.3.rs-8050715/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8050715/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground\u003c/strong\u003e: Cannabis-based products are increasingly used worldwide for chronic pain. However, there is a lack of reliable instruments assessing cannabis exposure.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eObjective\u003c/strong\u003e: To develop a questionnaire measuring the use of cannabis to manage chronic pain and assess its reliability.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethod\u003c/strong\u003e: A 24-item questionnaire assessing pain conditions, the type of cannabis products that were used, the methods of use, the concentration of main cannabinoids, and the use of other pain therapies was developed. An expert committee was convened to enhance the content validity of the questionnaire, to improve it, and a longitudinal survey was conducted to test the test-retest reliability of the final version.\u003c/p\u003e\n\u003cp\u003eA two-round survey of 158 participants with chronic pain was conducted between November 2023 and January 2024. Kappa and weighted kappa coefficients were calculated to assess the agreement between the responses of the two rounds. According to the criteria of Landis and Koch, items with a kappa ≥ 0.61 were considered as having a high reliability.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults\u003c/strong\u003e: The average age of participants was 38 years and the proportion of females was 53.5%. Most of the items assessing the use of cannabis products yielded a high reliability (kappa ≥ 0.61). Items with moderate reliability (0.41 ≤ Kappa \u0026lt; 0.61) included the type of pain and the type of cannabinoids used.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion\u003c/strong\u003e: The results suggest that the questionnaire developed in this study is a reliable tool for assessing cannabis use in patients with chronic pain in clinical or research settings.\u003c/p\u003e","manuscriptTitle":"Reliability of a self-reported questionnaire assessing the use of cannabis products to treat chronic pain","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-11-10 04:53:51","doi":"10.21203/rs.3.rs-8050715/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"d031014d-1175-481e-8742-4ddf6ce96eb3","owner":[],"postedDate":"November 10th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":57695722,"name":"Epidemiology"}],"tags":[],"updatedAt":"2025-11-10T04:53:51+00:00","versionOfRecord":[],"versionCreatedAt":"2025-11-10 04:53:51","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8050715","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8050715","identity":"rs-8050715","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0